Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 3 August 2005. doi:10.1136/ard.2005.040642
Annals of the Rheumatic Diseases 2006;65:360-365
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ard.2005.040642v1
ard.2005.040642v2
65/3/360    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meulenbelt, I
Right arrow Articles by Slagboom, P E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meulenbelt, I
Right arrow Articles by Slagboom, P E

EXTENDED REPORT

Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study

I Meulenbelt 1, M Kloppenburg 2,3, H M Kroon 4, J J Houwing-Duistermaat 5, P Garnero 6, M-P Hellio Le Graverand 7, J DeGroot 8, P E Slagboom 1

1 Department of Molecular Epidemiology, Leiden University Medical Centre, Leiden, Netherlands
2 Department of Rheumatology, Leiden University Medical Centre
3 Department of Clinical Epidemiology and Haematology, Leiden University Medical Centre
4 Department of Radiology, Leiden University Medical Centre
5 Department of Medical Statistics, Leiden University Medical Centre
6 Synarc, Lyon, France
7 Pfizer Global Research and Development, Croton, Connecticut, USA
8 Business Unit Biomedical Research, TNO Quality of Life, Leiden

Correspondence to:
Correspondence to:
Dr Ingrid Meulenbelt
Leiden University Medical Centre, Section of Molecular Epidemiology, Wassenaarseweg 72, 2333 AL Leiden, Netherlands; i.meulenbelt{at}lumc.nl

Objective: To assess the relation between the urinary concentrations of type II collagen C-telopeptide (UCTX-II) and radiographic signs of osteoarthritis (ROA) in the GARP (Genetics, Arthrosis and Progression) study.

Methods: UCTX-II levels were measured in GARP study participants, who are sibling pairs predominantly with symptomatic osteoarthritis at multiple sites. Kellgren and Lawrence scores were used to assess ROA in the knees, hips, hands, and vertebral facet joints, and spinal disc degeneration. A proportionate score was made for each joint location, based on the number of joints with ROA. The sum total ROA score represents a measure of cartilage abnormalities within each patient. By using linear mixed models the total ROA score and the joint site specific ROA scores were correlated with the UCTX-II level.

Results: In 302 subjects the mean (SD) and median (range) for UCTX-II were 265 (168) and 219 (1346) ng/mmol creatine, respectively. There was a significant association between the total ROA score and UCTX-II levels. Subsequent multivariate analysis showed that the joint site specific ROA score at all joint sites, except for spinal disc degeneration, contributed independently to this association.

Conclusions: The total ROA score of GARP patients, representing cartilage abnormalities at the most prevalent ROA joint locations, showed an excellent correlation with UCTX-II levels. The specific ROA scores at the hip, hand, facet, and knee joints additively and independently explained this association. Even in patients with osteoarthritis at multiple sites, UCTX-II may be a sensitive quantitative marker of ROA.


Keywords: osteoarthritis; CTX-II; GARP study; biomarker




This article has been cited by other articles:


Home page
Ann Rheum DisHome page
M Deberg, J-E Dubuc, A Labasse, C Sanchez, E Quettier, A Bosseloir, J-M Crielaard, and Y Henrotin
One-year follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement
Ann Rheum Dis, February 1, 2008; 67(2): 168 - 174.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
P. Garnero
New Biochemical Markers of Cartilage Turnover in Osteoarthritis: Recent Developments and Remaining Challenges
IBMS BoneKEy, January 1, 2007; 4(1): 7 - 18.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism